Pershing Square

Activist hedge fund manager Bill Ackman was dealt another blow this week when he came out on the losing side of a proxy battle to place three Pershing Square representatives on the board of Automatic Data Processing (NASDAQ: ADP). Ackman’s nominees received votes from less than 20 percent of...

Chipotle Mexican Grill, Inc. (NYSE: CMG) is again on the verge of a major technical breakdown. Chipotle stock peaked at $758.61 back in mid-2015 before a series of food safety outbreaks sent the company’s sales and share price tumbling. After finding support at $352 in late 2016, Chipotle...

This week, Pershing Square Capital’s Bill Ackman doubled down on his calls for change at Automatic Data Processing (NASDAQ: ADP), outlining a number of things he believes the company could do to unlock shareholder value. In a new slideshow presentation, Ackman clarified his calls for...

Billionaire investor Bill Ackman's activist campaign against Automatic Data Processing (NASDAQ: ADP) is turning nasty, the company's CEO Carlos Rodriguez explained to CNBC's Jim Cramer. Rodriguez spoke with Ackman before he went public and vocal with his proxy contest and asked for a...

Last week was big for activist investors, with Barington Capital Group and NuOrion Partners toppling Avon Products, Inc. (NYSE: AVP)’s CEO, Nelson Peltz and Bill Ackman forcing out Mondelez International Inc (NASDAQ: MDLZ)’s CEO, and Ackman’s Pershing Square inciting a drop in...

First tweets say a lot about a person, like what’s worth breaking silence for. When Goldman Sachs Group Inc (NYSE: GS) CEO Lloyd Blankfein composed his first Twitter Inc (NYSE: TWTR) post last month, he knew it would carry weight. Blankfein joined the online community in 2011 and remained a...

Restaurant Brands International Inc (NYSE: QSR) fell more than 1 percent Wednesday on news that Pershing Square Capital Management divested a 10 million share block. But the sale wasn't reflective of any negative sentiment toward the company. It was “simply for portfolio management...

Some of the largest and most successful investors in the world presented their best ideas this week at the Ira Sohn Conference in New York. In case you missed it, here’s some of the highlights from Benzinga Pro’s coverage of the event: Rundown Of Pro's Sohn Coverage Totem...

“Baby Buffett” may be outgrowing the endearing sobriquet. In 2015, Forbes bestowed Bill Ackman that label for his effort to build a conglomerate around real estate, just as Berkshire Hathaway’s (NYSE: BRK-A)(NYSE: BRK-B) Warren Buffett had done with insurance. And Monday, the...

Last week, Pershing Square CEO Bill Ackman told Bloomberg he would likely shy away from pharmaceutical companies following his $4 billion loss in Valeant Pharmaceuticals Intl Inc (NYSE: VRX). Perhaps Ackman meant it for investments, but not for research. His firm is still working to advance the...

Initiating coverage on Herbalife Ltd. (NYSE: HLF), Tigress Financial Partners said nobody has ever worked so hard to discredit the company, yet no company has ever stood up as well as Herbalife. Ivan Feinseth, director of research, noted that following Pershing Square branding it as a pyramid...

On April 9, the Wall Street Journal reported, quoting sources, Mondelez International Inc (NASDAQ: MDLZ) is seeking to replace its CEO Irene Rosenfeld. Does a potential exit by Rosenfeld mean more power for billionaire investor Warren Buffett, with whom Rosenfeld had run-ins in the past? Update...

There has been much talk of Bill Ackman losing his magic touch over his disastrous bets on Valeant Pharmaceuticals Intl Inc (NYSE: VRX), where he lost $4.6 billion, and his infamous short on Herbalife Ltd.(NYSE: HLF), which has gained 22 percent on the year and sparked a movie release on his...

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) investors were disappointed to see that popular vocal activist investor Bill Ackman finally abandoned his stake in Valeant for what was likely nearly a $4 billion loss on the trade. On the surface, a heavily-invested activist finally throwing in the...

After a headline-filled tenure, Bill Ackman's investment in Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is over. As first reported by CNBC and TheStreet, and later confirmed to Benzinga, the activist investor's firm Pershing Square sold its 27.2 million share position at $11 per share,...